Eli Lilly & Co. (LLY)

Statement of Cash Flows

Difficulty: Beginner

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company’s statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Eli Lilly & Co., Consolidated Statement of Cash Flows

USD $ in thousands

	12 months ended	Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Net income (loss)
	Depreciation and amortization
	Change in deferred income taxes
	Stock-based compensation expense
	Acquired in-process research and development
	Other non-cash operating activities, net
	Receivables, (increase) decrease
	Inventories, (increase) decrease
	Other assets, (increase) decrease
	Income taxes payable, increase (decrease)
	Accounts payable and other liabilities, increase (decrease)
	Other changes in operating assets and liabilities, net of acquisitions and divestitures
	Adjustments to reconcile net income (loss) to cash flows from operating activities
	Net cash provided by operating activities
	Purchases of property and equipment
	Proceeds from disposals of property and equipment
	Cash (restricted) released for pending acquisition
	Proceeds from sales and maturities of short-term investments
	Purchases of short-term investments
	Proceeds from sales of noncurrent investments
	Purchases of noncurrent investments
	Proceeds from sale of product rights
	Purchase of product rights
	Purchases of in-process research and development
	Cash paid for acquisitions, net of cash acquired
	Other investing activities, net
	Net cash (used for) provided by investing activities
	Dividends paid
	Net change in short-term borrowings
	Proceeds from issuance of long-term debt
	Repayments of long-term debt
	Purchases of common stock
	Net proceeds from Elanco initial public offering
	Other financing activities, net
	Net cash provided by (used for) financing activities
	Effect of exchange rate changes on cash and cash equivalents
	Net increase (decrease) in cash and cash equivalents
	Cash and cash equivalents at beginning of year
	Cash and cash equivalents at end of year

Based on: 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19).

Item	Description	The company
Net cash provided by operating activities	Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.	Eli Lilly & Co.’s net cash provided by operating activities increased from 2016 to 2017 but then slightly declined from 2017 to 2018.
Net cash (used for) provided by investing activities	Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.	Eli Lilly & Co.’s net cash (used for) provided by investing activities declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.
Net cash provided by (used for) financing activities	Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.	Eli Lilly & Co.’s net cash provided by (used for) financing activities increased from 2016 to 2017 but then declined significantly from 2017 to 2018.

	Eli Lilly & Co.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality